Circulating levels of omentin-1 in patients with breast cancer
Archives of Medical Laboratory Sciences,
Vol. 2 No. 1 (2016),
9 April 2016
https://doi.org/10.22037/amls.v2i1.12219
Abstract
Background: It seems adipocytokines play an important role in breast cancer. Omentin-1 is a novel discovered plasma adipocytokine produced mainly in visceral adipose tissue. The aim of present study was to estimate. Circulating levels of omentin-1 in postmenopausal breast cancer patients as compare to healthy postmenopausal subjects.
Materials and Methods: This study consisted of 30 postmenopausal women with newly diagnosed breast cancer and 30 healthy postmenopausal subjects aged 45 to 70 years. Serum levels of omentin-1 were measured by enzyme-linked immunosorbent assay.
Results: The mean age of the case group was 54.3±8.3 years, and the control group was 50.3±3.2 years. The mean serum levels of omentin-1 in the case group were 73.1±29.7 ng/mL and in the control group were 108.8±65.4 ng/mL. The mean serum omentin-1 levels were found to be significantly lower in breast cancer patients (P=0.009). We also demonstrated the negative correlation of Omentin-1 with BMI in both groups (p=0.005), however, we did not find any association between age and serum omentin-1 levels (P=NS).
Conclusion: Our studied showed that Omentin-1 level was significantly reduced in the breast cancer patients as compare to healthy controls. Decreased omentin-1 levels may contribute to the development of cancer, however determination of its role and mechanisms needs more investigations. To sum up, our data suggest that omentin-1 can be used as a marker for early detection of breast cancer in postmenopausal women.
- Breast cancer
- omentin
- serum
How to Cite
References
Khan S, Shukla S, Sinha S, Meeran SM. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine & growth factor reviews. 2013;24(6):503-13.
Lee Y-C, Yang Y-H, Su J-H, Chang H-L, Hou M-F, Yuan S-SF. High visfatin expression in breast cancer tissue is associated with poor survival. Cancer Epidemiology Biomarkers & Prevention. 2011;20(9):1892-901.
Pezeshkane bedoon marz[Persian]; Available at: http://www.pezeshk.us/?p=23319. 29 July
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I. Breast Cancer in Iran:
An Epidemiological Review. The Breast Journal 2007; 13(4): 383–91.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine. 2003;348(17):1625-38.
Carmichael A. Review article: Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG: An International Journal of Obstetrics & Gynaecology. 2006;113(10):1160-6.
Proenca A, Sertié R, Oliveira A, Campaaa A, Caminhotto R, Chimin P, et al. New concepts in white adipose tissue physiology. Brazilian Journal of Medical and Biological Research. 2014; 47(3): 192-205.
Fantuzzi G. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology. 2005;115(5):911-9.
Smitka K, Marešová D. Adipose tissue as an endocrine organ: An update on pro-inflammatory and anti-inflammatory microenvironment. Prague medical report. 2015;116(2):87.
Scherer PE. Adipose tissue from lipid storage compartment to endocrine organ. Diabetes. 2006;55(6):1537-45.
Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology-Endocrinology and Metabolism. 2006;290(6):E1253-E61.
Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends in cardiovascular medicine. 2010;20(5):143-8.
Tan Y-L, Zheng X-L, Tang C-K. The protective functions of omentin in cardiovascular diseases. Clinica Chimica Acta. 2015;448:98-106.
Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC medical genetics. 2011;12(1):1.
Shibata R, Takahashi R, Kataoka Y, Ohashi K, Ikeda N, Kihara S, et al. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertension Research. 2011;34(12):1309-12.
Yan P, Liu D, Long M, Ren Y, Pang J, Li R. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 2011;119(4):257-63.
Pan H-Y, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice. 2010;88(1):29-33.
Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer. 2002;94(12):3127-34.
Tan BK, Adya R, Farhatullah S, Chen J, Lehnert H, Randeva HS. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes. 2010;59(12):3023-31.
Halabis M, Dziedzic M, Warchulinska J, Kaznowska-Bystryk I, Solski J. Omentin-a new adipokine with many roles to play. Current Issues in Pharmacy and Medical Sciences. 2015; 28(3): 176-80.
Fazeli MS, Dashti H, Akbarzadeh S, Assadi M, Aminian A, Keramati MR, et al. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine. 2013;62(1):81-5.
Uyeturk U, Alcelik A, Aktas G, Tekce BK. Post-treatmentBUON. 2014;19(3):681-5.
Uyeturk U, Sarıcı H, Tekce BK, Eroglu M, Kemahlı E, Uyeturk U, et al. Serum omentin level in patients with prostate cancer. Medical Oncology. 2014;31(4):1-5.
Shen X-D, Zhang L, Che H, Zhang Y-Y, Yang C, Zhou J, et al. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer. Cytokine. 2016;77:50-5.
Zhang Y-Y, Zhou L-M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. European journal of pharmacology. 2013;698(1):137-44.
de Souza Batista CM, Yang R-Z, Lee M-J, Glynn NM, Yu D-Z, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655-61.
Cai R, Wei L, Di J, Yu H, Bao Y, Jia W. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients]. Zhonghua yi xue za zhi. 2009;89(6):381-4.
Šenolt L, Polanská M, Filková M, Cerezo LA, Pavelka K, Gay S, et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2009:annrheumdis119735.
Derosa G, Fogari E, D’Angelo A, Bianchi L, Bonaventura A, Romano D, et al. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation. 2013;36(4):914-20
- Abstract Viewed: 106 times
- PDF Downloaded: 53 times